Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • AbbVie opts for North Carolina to house $1.4bn manufacturing site
  • Manufacturing

AbbVie opts for North Carolina to house $1.4bn manufacturing site

Pharmaceutical Technology

This Durham-based facility will be AbbVie's first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

pharminent April 23, 2026 (Last updated: April 23, 2026)

Pharmaceutical Technology

This Durham-based facility will be AbbVie’s first manufacturing site in the state, and will become a centre of excellence for SVP production.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: MSD teams up with Google Cloud on agentic AI transformation
Next: Sanofi receives FDA approval for Tzield in paediatric diabetes

Related Stories

  • Manufacturing

pharminent June 17, 2026
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

pharminent June 15, 2026
  • Manufacturing

FDA imposes import alert on Indian plant after inspectors flag GMP failings

pharminent June 12, 2026

You May Have Missed

  • News

pharminent June 22, 2026
sample_feature_2026-06-22
  • News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026
  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.